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inserm-00701498, version 1 -25 May 2012 The possibility to transplant primary human hepatocytes into transgenic immunodeficient mice with hepatocyte lethal phenotype (uPA-SCID and Fah/Rag2/IL-2r null mice) and to subsequently infect these human hepatocytes yielded the first small animal models to study HCV infection in vivo. 4, 5 Drawbacks of these models are however their high 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 inserm-00701498, version 1 -25 May 2012 . However, the lack of robust HCV replication in mouse hepatocytes and the need for CRE-expressing recombinant HCVcc currently precludes the study of infection using patient-derived HCV and the investigation of virus-host interactions during replication and particle production. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 inserm-00701498, version 1 -25 May 2012 Since a recent study has shown that mouse hepatoma cell lines are able to produce infectious virions following expression of mouse or human apolipoprotein E, 12 the identification of species-specific restriction factors for viral replication will be most likely the final step required to produce humanized transgenic mice recapitulating the entire viral life cycle. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 inserm-00701498, version 1 -25 May 2012 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 inserm-00701498, version 1 -25 May 2012 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 inserm-00701498, version 1 -25 May 2012 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
